Citadel Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181M Buy
1,044,900
+35,000
+3% +$7.17M 0.03% 493
2025
Q4
$259M Sell
1,009,900
-969,100
-49% -$254M 0.04% 387
2025
Q3
$515M Buy
1,979,000
+562,700
+40% +$148M 0.08% 178
2025
Q2
$346M Sell
1,416,300
-533,100
-27% -$133M 0.06% 238
2025
Q1
$516M Buy
1,949,400
+275,900
+16% +$74.6M 0.1% 121
2024
Q4
$425M Buy
1,673,500
+116,000
+7% +$31.1M 0.07% 187
2024
Q3
$493M Buy
1,557,500
+367,000
+31% +$131M 0.1% 136
2024
Q2
$445M Buy
1,190,500
+278,300
+31% +$94M 0.09% 143
2024
Q1
$316M Buy
912,200
+312,600
+52% +$118M 0.06% 229
2023
Q4
$275M Buy
599,600
+221,600
+59% +$109M 0.05% 241
2023
Q3
$184M Buy
378,000
+11,000
+3% +$5.17M 0.04% 347
2023
Q2
$164M Buy
367,000
+29,800
+9% +$15M 0.03% 391
2023
Q1
$164M Sell
337,200
-115,100
-25% -$56.9M 0.04% 403
2022
Q4
$232M Buy
452,300
+181,700
+67% +$95.5M 0.05% 288
2022
Q3
$131M Buy
270,600
+58,900
+28% +$28.7M 0.03% 464
2022
Q2
$99.1M Sell
211,700
-75,400
-26% -$33.5M 0.03% 579
2022
Q1
$125M Sell
287,100
-32,700
-10% -$13.7M 0.03% 554
2021
Q4
$148M Buy
319,800
+45,700
+17% +$20.2M 0.03% 461
2021
Q3
$107M Buy
274,100
+150,100
+121% +$63.7M 0.02% 622
2021
Q2
$54.9M Buy
124,000
+32,100
+35% +$14M 0.01% 1056
2021
Q1
$38.5M Sell
91,900
-33,500
-27% -$13.4M 0.01% 1268
2020
Q4
$51.4M Buy
125,400
+6,500
+5% +$2.7M 0.01% 930
2020
Q3
$49.2M Sell
118,900
-48,700
-29% -$19.6M 0.01% 874
2020
Q2
$65M Sell
167,600
-9,400
-5% -$3.52M 0.02% 635
2020
Q1
$55.6M Buy
177,000
+74,000
+72% +$25M 0.03% 592
2019
Q4
$37.8M Sell
103,000
-67,300
-40% -$21.3M 0.02% 968
2019
Q3
$43.5M Buy
170,300
+31,800
+23% +$8.92M 0.02% 845
2019
Q2
$36.7M Sell
138,500
-57,100
-29% -$14.5M 0.02% 920
2019
Q1
$52M Buy
195,600
+101,700
+108% +$29.3M 0.03% 670
2018
Q4
$26.9M Sell
93,900
-2,300
-2% -$729K 0.01% 1003
2018
Q3
$32.6M Buy
96,200
+29,300
+44% +$9.52M 0.01% 1027
2018
Q2
$19.9M Sell
66,900
-106,600
-61% -$31.2M 0.01% 1327
2018
Q1
$46.6M Buy
173,500
+70,500
+68% +$19.1M 0.03% 636
2017
Q4
$25.6M Buy
103,000
+13,100
+15% +$3.23M 0.02% 1023
2017
Q3
$21.9M Sell
89,900
-34,800
-28% -$8.53M 0.02% 1014
2017
Q2
$30M Buy
124,700
+71,400
+134% +$16.2M 0.03% 756
2017
Q1
$11M Buy
53,300
+27,000
+103% +$5.58M 0.01% 1368
2016
Q4
$5.37M Buy
26,300
+4,100
+18% +$782K 0.01% 1929
2016
Q3
$3.93M Sell
22,200
-4,000
-15% -$694K ﹤0.01% 2228
2016
Q2
$4.71M Buy
26,200
+800
+3% +$142K 0.01% 1868
2016
Q1
$4.65M Sell
25,400
-21,600
-46% -$3.75M 0.01% 1845
2015
Q4
$8.39M Sell
47,000
-7,400
-14% -$1.3M 0.01% 1410
2015
Q3
$9.74M Sell
54,400
-87,700
-62% -$16.2M 0.01% 1367
2015
Q2
$27.2M Buy
142,100
+70,700
+99% +$13.1M 0.02% 816
2015
Q1
$12.7M Buy
71,400
+17,700
+33% +$2.8M 0.01% 1265
2014
Q4
$7.71M Sell
53,700
-6,600
-11% -$902K 0.01% 1604
2014
Q3
$7.86M Buy
60,300
+1,400
+2% +$178K 0.01% 1571
2014
Q2
$7.52M Sell
58,900
-28,100
-32% -$3.33M 0.01% 1492
2014
Q1
$9.81M Buy
87,000
+38,800
+80% +$4.04M 0.01% 1278
2013
Q4
$4.97M Sell
48,200
-45,400
-49% -$4.45M 0.01% 1693
2013
Q3
$8.74M Sell
93,600
-7,500
-7% -$688K 0.01% 1185
2013
Q2
$8.53M Buy
+101,100
New +$7.98M 0.01% 1171

Other funds holding HUM

Citadel Advisors's HUM Position: Q1 2026 in Review

Citadel Advisors increased its Humana (HUM) stake by 320% in Q1 2026, buying an estimated $22.1M and bringing the position to 141,650 shares worth $24.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Citadel Advisors first reported a position in HUM in Q2 2013 and has held it in 50 quarters since. The position peaked at $774M in Q3 2023. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Citadel Advisors held 141,650 shares of Humana worth $24.6M as of Q1 2026.
  • Citadel Advisors bought 107,899 Humana shares in Q1 2026, an estimated $22.1M.
  • Humana made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2083 holding.
  • Citadel Advisors first reported a position in Humana in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Humana position peaked at $774M in Q3 2023.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.